RIGL - Rigel Pharmaceuticals GAAP EPS of $0.63, revenue of $53.33M beats by $9.46M
2025-05-06 16:30:26 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
- Rigel Looks Interesting, But Let's Wait For A Lower Price
- Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript
- Rigel Pharmaceuticals Q1 2025 Earnings Preview
- Rigel settles patent litigation regarding its immune thrombocytopenia treatment